Medacta Group S.A.
MEDGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $590,580 | $510,778 | $437,122 | $363,126 |
| % Growth | 15.6% | 16.9% | 20.4% | – |
| Cost of Goods Sold | $191,141 | $162,931 | $131,866 | $101,879 |
| Gross Profit | $399,439 | $347,847 | $305,256 | $261,247 |
| % Margin | 67.6% | 68.1% | 69.8% | 71.9% |
| R&D Expenses | $21,392 | $20,318 | $16,223 | $11,306 |
| G&A Expenses | $21,342 | $65,801 | $60,621 | $49,831 |
| SG&A Expenses | $231,891 | $252,472 | $220,215 | $182,386 |
| Sales & Mktg Exp. | $210,549 | $186,671 | $159,594 | $132,555 |
| Other Operating Expenses | $55,324 | $614 | $7,354 | $8,994 |
| Operating Expenses | $308,607 | $273,404 | $243,792 | $202,686 |
| Operating Income | $90,832 | $74,443 | $61,464 | $58,777 |
| % Margin | 15.4% | 14.6% | 14.1% | 16.2% |
| Other Income/Exp. Net | -$3,063 | -$15,717 | -$6,672 | -$3,326 |
| Pre-Tax Income | $87,769 | $58,726 | $54,792 | $55,451 |
| Tax Expense | $14,883 | $11,364 | $8,543 | $3,930 |
| Net Income | $72,886 | $47,362 | $46,249 | $51,521 |
| % Margin | 12.3% | 9.3% | 10.6% | 14.2% |
| EPS | 3.66 | 2.37 | 2.32 | 2.58 |
| % Growth | 54.4% | 2.2% | -10.1% | – |
| EPS Diluted | 3.65 | 2.37 | 2.31 | 2.58 |
| Weighted Avg Shares Out | 19,915 | 19,952 | 19,977 | 19,996 |
| Weighted Avg Shares Out Dil | 19,955 | 19,952 | 19,996 | 20,004 |
| Supplemental Information | – | – | – | – |
| Interest Income | $221 | $103 | $348 | $332 |
| Interest Expense | $7,512 | $6,830 | $3,663 | $3,442 |
| Depreciation & Amortization | $65,231 | $43,133 | $37,500 | $30,734 |
| EBITDA | $160,512 | $119,644 | $106,957 | $97,815 |
| % Margin | 27.2% | 23.4% | 24.5% | 26.9% |